CYTOCHROME P450-BASED CANCER GENE THERAPY: RECENT ADVANCES AND FUTURE PROSPECTS
- 1 January 1999
- journal article
- review article
- Published by Taylor & Francis in Drug Metabolism Reviews
- Vol. 31 (2) , 503-522
- https://doi.org/10.1081/dmr-100101933
Abstract
(1999). CYTOCHROME P450-BASED CANCER GENE THERAPY: RECENT ADVANCES AND FUTURE PROSPECTS. Drug Metabolism Reviews: Vol. 31, No. 2, pp. 503-522.Keywords
This publication has 43 references indexed in Scilit:
- Cancer Gene Therapy by Direct Tumor Injections of a Nonviral T7 Vector Encoding a Thymidine Kinase GeneHuman Gene Therapy, 1998
- Mustard Prodrugs for Activation by Escherichia coli Nitroreductase in Gene-Directed Enzyme Prodrug TherapyJournal of Medicinal Chemistry, 1997
- Reductase Enzyme Expression Across the National Cancer Institute Tumor Cell Line Panel: Correlation With Sensitivity to Mitomycin C and EO9JNCI Journal of the National Cancer Institute, 1996
- P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclaturePharmacogenetics, 1996
- Gene therapy strategies for novel cancer therapeuticsCurrent Opinion in Oncology, 1996
- Gene Introduction Into Animal TissuesCritical Reviews in Therapeutic Drug Carrier Systems, 1995
- Experimental Tumor Therapy in Mice Using the Cyclophosphamide-Activating Cytochrome P450 2B1 GeneHuman Gene Therapy, 1994
- An unusual yet strongly conserved flavoprotein reductase in bacteria and mammalsTrends in Biochemical Sciences, 1991
- Interaction of Anticancer Drugs with Hepatic Monooxygenase EnzymesDrug Metabolism Reviews, 1989
- Sequential translocation of two phenobarbital-induced polysomal messenger ribonucleic acids from the nuclear envelope to the endoplasmic reticulumBiochemistry, 1981